Cover of Apple: Great Business, Bad Price? | EP 016

Apple: Great Business, Bad Price? | EP 016

Apple: Great Business, Bad Price? | EP 016

Listen for free

View show details

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.
Can Apple's ecosystem and cash generation justify a premium share price? This full review connects AI-enabled devices, Services, margins, capital returns and regulatory exposure to the investment case.The business and four financial reviewsApple sells integrated devices and earns recurring Services revenue. The September consensus reviews earnings and financial quality, profitability and margins, balance-sheet strength and leverage, and capex and investment intensity. We cross-checked those findings with Apple's current primary financial statements, correcting stale balance-sheet figures and separating a one-time tariff refund from recurring operating gains.June-quarter revenue was USD109.4 billion and reported EPS USD2.02. The reported 50.1% gross margin included approximately two percentage points of tariff-refund benefit, while EPS included eleven cents. Nine-month operating cash flow of USD117.0 billion less USD6.8 billion physical capex produces approximately USD110.2 billion simple free cash flow. R&D is an operating expense and is not subtracted a second time. At June27, cash plus all current and non-current marketable securities totaled USD146.5 billion versus USD84.3 billion interest-bearing debt, leaving about USD62.2 billion net cash under that definition. Cash and securities is not the same as bank cash alone.Current-price scenario comparisonLatest available reference at finalization: AAPL.NASDAQ, USD336.64, October9,2026 close, sourced from the governed EOD market record. October12 UAE morning precedes the US market opening. The source close timestamp is absent; the date and ingestion timestamp are recorded in the evidence package.The archived research endpoints are September18,2027 and September18,2031. At this recording they are roughly11months and4years11months ahead. They are the dated one-year/five-year research windows, not newly rolled forecasts exactly one/five years after October12.Path and return basis | September2027 | September2031Evidence-weighted base: price only | -1.4% | +18.8%Weighted base plus illustrative flat gross cash dividends | -1.1% | +20.4%Separately averaged bull: price only | +12.3% | +64.9%Averaged bull plus the same cash illustration | +12.7% | +66.5%Separately averaged bear: price only | -11.8% | -9.3%Averaged bear plus the same cash illustration | -11.4% | -7.7%These percentages are cumulative. The bull/bear values come from the publicly displayed averaged scenario table and differ in aggregation from the evidence-weighted synthesized base path. Neither presentation assigns scenario probabilities. The public research's dividend-reinvestment/net-yield metrics are a different calculation; we do not add dividends to those metrics again.Latest verified paid dividend: USD0.27 per share quarterly, paid August13,2026. An unchanged dividend gives USD1.08 over four payments and USD5.40 over twenty payments, about0.32% annual cash yield at the reference price. The illustration assumes those future payments remain flat, gross before tax, with no reinvestment and no FX conversion; future declarations can change. Paid dividends and projected cash are separate.The full thesisThe base case combines a durable ecosystem and recurring Services with valuation pressure. The bull case requires AI to improve upgrade demand, engagement or monetization after its costs. The bear case combines slower replacements, component/compute costs and less favorable distribution economics with multiple compression.The four quadrants separate core drivers and recurring frictions from less-certain upside and downside tails. Alpha gap: the business can be excellent while the stock's starting valuation absorbs much of its growth. Fourteen AI research contributions span multiple models and analytical frameworks; these are not fourteen independent human analysts. The key disagreement is whether AI creates a lasting upgrade cycle or mainly becomes a costly retention feature.Current search remedies restrict exclusivity, linked conditions and lengthy distribution arrangements; a blanket loss of all Apple payments is a downside scenario rather than a confirmed2027 outcome. Buybacks can support per-share earnings without creating a guaranteed price floor. New clinical wearable capabilities are speculative research opportunities, not approved products or confirmed insurer reimbursement.Complete evidence-weighted quarterly pathModel dates are forecast windows, not confirmed company earnings, product or court dates. The path is reproduced below with price-return percentages recalculated from the October9 close.Model window | Weighted target USD | Cumulative price return from USD336.642026-12-18 | 339.22 | +0.8%2027-03-18 | 332.81 | -1.1%2027-06-18 | 325.56 | -3.3%2027-09-18 | 331.97 | -1.4%2027-12-18 | 340.57 | +1.2%2028-03-18 | 336.31 | -0.1%2028-06-18 | 340.14 | +1.0%2028-09-18 | 342.01 | +1.6%2028-12-18 | 353.58 | +5.0%2029-03-18 | 352.48 | +4.7%2029-06-18 | 358.29 | +6.4%2029-09-18 | 364.78 | +8.4%2029-...
adbl_web_anon_alc_button_suppression_t1
No reviews yet